Pettavel J, Meyer A
Schweiz Med Wochenschr. 1979 May 26;109(21):794-6.
451 patients undergoing surgery for colorectal cancer showed synchronous hepatic metastases in 24.4% (110 cases). Survival of patients with hepatic metastases appears to depend on both the age of the patient and the site of metastatic deposit. A relatively good prognosis group with median survival of 14 months can be separated from the other patients with only 5 months survival. Survival of patients with hepatic metastases can thus be predicted and long-term survival (5 and 10 years) obtained by surgical excision of these metastases. Postoperative CEA determinations will also increase the rate of early surgery for hepatic metastases.
451例接受结直肠癌手术的患者中，24.4%（110例）出现同步肝转移。肝转移患者的生存似乎取决于患者年龄和转移灶部位。可将中位生存期为14个月的相对预后良好组与其他生存期仅5个月的患者区分开来。因此，肝转移患者的生存情况可以预测，通过手术切除这些转移灶可实现长期生存（5年和10年）。术后癌胚抗原（CEA）测定也将提高肝转移的早期手术率。
